09.17.2015 BioMedomics Receives NIH Grant for Sickle Cell Disease Test Development
Firm client BioMedomics, Inc recently received the outstanding news that they have been awarded a $222,950 grant from the National Institutes of Health for the development of quantitative Point of Care test for hemoglobin S (HbS) and hemoglobin F (HbF). The grant will be used to develop the tests to aid the treatment of Sickle Cell Disease patients. Read a PDF of the press release here. Visit the BioMedomics website here.